| HSY |
Report |
Net sales |
IN-LINE |
pred ~$2.650B vs. cons $2.636B |
MEDIUM |
| HSY |
Report |
Adjusted / operating diluted EPS |
BEAT |
pred ~$1.450 vs. cons $1.432 |
MEDIUM |
| HSY |
Report |
Operating gross profit |
BEAT |
pred ~$1.100B vs. cons $1.082B |
MEDIUM |
| HSY |
Guide |
FY26 net sales growth |
UNCHANGED |
guide 4%-5% vs. cons 4.67% implied |
MEDIUM |
| HSY |
Guide |
FY26 organic net sales growth |
UNCHANGED |
guide 2.5%-3.5% vs. cons 2.86% |
MEDIUM |
| HSY |
Guide |
FY26 adjusted EPS |
UNCHANGED |
guide $8.20-$8.52 vs. cons $8.431 |
MEDIUM |
| HSY |
Guide |
H2 FY26 gross-margin trajectory |
UNCHANGED |
guide >500 bps vs. cons UNVERIFIED |
LOW |
| HSY |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.0% |
— |
LOW |
| HSY |
Return |
5-day cumulative residual |
+0.5% (STABILIZE) |
STABILIZE — partial recovery after initial implicit-cut concern |
LOW |